Since its inception in 1992, bioskin has been recognized as a valuable partner for dermatological product development. Starting as a small Contract Research Organization (CRO) specialized in conducting early phase safety and efficacy trials, bioskin has grown into a full-service CRO offering global strategic consulting and regulatory services and all services for management of Phase I-IV drug trials and claim support/safety studies. bioskin is privately owned and headquartered in Hamburg, Germany and Napa, California.
bioskin is unique in its understanding and capabilities for both early and late phase development of dermatological and related products. A core expertise is the development of innovative test designs, integrating biophysical measurement methods to deliver objective data about skin function and structure to support traditional clinical endpoints. For global early and late phase studies bioskin partners with select, reliable partners throughout the world.